Literature DB >> 12142606

CD117 (KIT receptor) expression in Merkel cell carcinoma.

Lyndon D Su1, Douglas R Fullen, Lori Lowe, Patricia Uherova, Bertram Schnitzer, Riccardo Valdez.   

Abstract

The KIT receptor tyrosine kinase (CD117 antigen) is found in a variety of normal tissue cell types and in several malignant tumors, including acute myeloid leukemia. We recently encountered two tumors initially suspected as acute myeloid leukemia cutis and expressing CD117 that showed punctate positivity for cytokeratin 20 diagnostic for Merkel cell carcinoma. We evaluated 20 additional cases of MCC and found that 21 of 22 tumors (95%) expressed CD117. Intensity of CD117 expression did not appear to correlate with aggressive behavior. While the function of the KIT receptor in MCC is not known, its pathogenic role in other malignant neoplasms suggests the possibility of a similar role in MCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142606     DOI: 10.1097/00000372-200208000-00001

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  15 in total

Review 1.  Merkel cell carcinoma of skin: diagnosis and management strategies.

Authors:  Michael Poulsen
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status.

Authors:  Aleodor A Andea; Raj Patel; Selvarangan Ponnazhagan; Sanjay Kumar; Patricia DeVilliers; Darshana Jhala; Isam E Eltoum; Gene P Siegal
Journal:  Hum Pathol       Date:  2010-07-01       Impact factor: 3.466

3.  CD117, Ki-67, and p53 predict survival in neuroendocrine carcinomas, but not within the subgroup of small cell lung carcinoma.

Authors:  Brian S Erler; Matthew M Presby; Meredith Finch; Allison Hodges; Kari Horowitz; Arthur A Topilow; Theodore Matulewicz
Journal:  Tumour Biol       Date:  2010-11-08

4.  Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus.

Authors:  Helka Sahi; Virve Koljonen; Heli Kavola; Caj Haglund; Erkki Tukiainen; Harri Sihto; Tom Böhling
Journal:  Virchows Arch       Date:  2012-09-14       Impact factor: 4.064

5.  A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).

Authors:  Wolfram E Samlowski; James Moon; Ralph J Tuthill; Michael C Heinrich; Naomi S Balzer-Haas; Stuart A Merl; Ronald C DeConti; John A Thompson; Merle T Witter; Lawrence E Flaherty; Vernon K Sondak
Journal:  Am J Clin Oncol       Date:  2010-10       Impact factor: 2.339

6.  Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas.

Authors:  Stefano La Rosa; Silvia Uccella; Linda Dainese; Silvia Marchet; Claudia Placidi; Davide Vigetti; Carlo Capella
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

7.  Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.

Authors:  Heather M Ames; Christopher K Bichakjian; Grace Y Liu; Katherine I Oravecz-Wilson; Douglas R Fullen; Monique E Verhaegen; Timothy M Johnson; Andrzej A Dlugosz; Theodora S Ross
Journal:  J Invest Dermatol       Date:  2011-06-23       Impact factor: 8.551

8.  Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis.

Authors:  Paul W Harms; Rajiv M Patel; Monique E Verhaegen; Thomas J Giordano; Kevin T Nash; Craig N Johnson; Stephanie Daignault; Dafydd G Thomas; Johann E Gudjonsson; James T Elder; Andrzej A Dlugosz; Timothy M Johnson; Douglas R Fullen; Christopher K Bichakjian
Journal:  J Invest Dermatol       Date:  2012-12-06       Impact factor: 8.551

9.  Which are the cells of origin in merkel cell carcinoma?

Authors:  Thomas Tilling; Ingrid Moll
Journal:  J Skin Cancer       Date:  2012-12-13

10.  Merkel cell carcinoma: chemotherapy and emerging new therapeutic options.

Authors:  Laura Desch; Rainer Kunstfeld
Journal:  J Skin Cancer       Date:  2013-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.